• help
  • PC | SP
  • JP | EN
          
検索対象：     
報告書番号：
※ 半角英数字
 年 ～ 
 年
全てクリア
前の画面に戻る

Production and synthesis of a novel $$^{191}$$Pt-labeled platinum complex and evaluation of its biodistribution in healthy mice

新規$$^{191}$$Pt標識白金錯体の製作・合成と健康マウスにおける生体内分布の評価

面川 真里奈*; 木村 寛之*; 初川 雄一*; 河嶋 秀和*; 塚田 和明  ; 屋木 祐介*; 内藤 行基*; 安井 裕之*

Omokawa, Marina*; Kimura, Hiroyuki*; Hatsukawa, Yuichi*; Kawashima, Hidekazu*; Tsukada, Kazuaki; Yagi, Yusuke*; Naito, Yuki*; Yasui, Hiroyuki*

$$^{191}$$Pt was produced via the (n,2n) reaction induced by accelerator neutrons. [$$^{191}$$Pt]FGC-Pt was obtained through the accelerator neutron irradiation of FGC-Pt and K$$_{2}$$PtCl$$_{4}$$. Highly purified [$$^{191}$$Pt]FGC-Pt was obtained using the latter method, which suggests that the synthetic method using a $$^{191}$$Pt-labeled platinum reagent is suitable for the radioactivation of platinum complexes. We also investigated whether a significant correlation existed between the biodistribution of FGC-Pt and [$$^{191}$$Pt]FGC-Pt in healthy mice 24 h after tail vein administration. These results suggest that $$^{191}$$Pt-labeled compounds, synthesized using radioactive platinum reagents, can be used to confirm the biodistribution of platinum compounds. Our study on the biodistribution of [$$^{191}$$Pt]FGC-Pt is expected to contribute to the development of novel platinum-based drugs in the future.

使用言語

 :

English

掲載資料名

 :

Bioorganic & Medicinal Chemistry

巻

 :

97

号

 :

ページ数

 :

p.117557_1 - 117557_6

発行年月

 :

2024/01

発表会議名

 :

開催年月

 :

開催都市

 :

開催国

 :

キーワード

 :

Pt-191ラベル錯体合成; 薬剤合成; 体内分布

特許データ

 :

PDF

 :


論文URL

 :

https://doi.org/10.1016/j.bmc.2023.117557

研究データの公開先DOI

 :

使用施設

 :

広報プレスリリース

 :

論文解説記事
(成果普及情報誌)

 :

受委託・共同研究相手機関

 :

量研機構; 京都薬科大学

Access

 :

- Accesses

InCites™

 :

パーセンタイル：0.01

分野：Biochemistry & Molecular Biology

Altmetrics

 :

[CLARIVATE ANALYTICS], [WEB OF SCIENCE], [HIGHLY CITED PAPER & CUP LOGO] and [HOT PAPER & FIRE LOGO] are trademarks of Clarivate Analytics, and/or its affiliated company or companies, and used herein by permission and/or license.

前の画面に戻る